Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogene 111 (RNA5SP111)
- Target
- RNA5SP111
- Molecular classification
- Pseudogene, Non-coding RNA, rRNA pseudogene
01
Overview
5S ribosomal RNA pseudogene 111 (RNA5SP111) is a non-coding RNA pseudogene sequence derived from the 5S ribosomal RNA gene family. The canonical 5S rRNA is a ~120 nucleotide RNA essential for ribosome function and protein synthesis, acting as a structural and possibly catalytic component in the ribosome. Pseudogenes of 5S rRNA, such as RNA5SP111, are considered non-functional genomic elements generated by duplication events or retrotransposition and do not contribute to ribosome assembly or protein synthesis. While the 5S rRNA gene and its functional transcript play crucial roles in translation and ribosome biogenesis, the pseudogene does not have direct biological, molecular, or pharmacological function. Some pseudogenes in other contexts may act as non-coding RNAs with regulatory capacity, but for RNA5SP111, no functional data is available.
- Other names
- RN5S111RNA5SP111RNA, 5S ribosomal 111
02
Mechanism of action
None applicable to drugs, as no targeted therapeutics are developed for non-functional pseudogenes.
03
Biological functions
Generally none, as pseudogenes are non-functional remnants of gene duplication or retrotransposition eventsHowever, recent evidence in cancer genomics suggests that some expressed pseudogenes can act as regulatory RNAs (competing for microRNAs or affecting parental gene expression), but this is not established for RNA5SP111 specifically
04
Disease associations
None directly attributedFor pseudogenes in general, differential pseudogene expression has been shown to correlate with cancer subtypes and prognosis, implying they could potentially act as biomarkers or molecular regulators in oncogenesis
05
Safety considerations
None relevant; pseudogenes do not encode proteins and lack direct functional biological rolesSafety concerns in drug targeting do not apply
06
Interacting drugs
None known
2 more in the full profile.
07
Biomarkers
Potentially, in large-scale transcriptomic studies, some pseudogenes’ expression patterns (not specifically RNA5SP111) are proposed as prognostic cancer biomarkers
Beyond the preview
Go deeper on 5S ribosomal RNA pseudogene 111 (RNA5SP111).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 111 (RNA5SP111).